Ridgetech Files Prospectus for $184.7M ATM, Potential 40x Share Dilution

summarizeSummary

Ridgetech filed a prospectus supplement for a new $184.7 million at-the-market offering program, which could increase shares outstanding by over 40 times at the assumed $1.23 price, following the termination of a prior $200 million ATM program that nearly doubled the share count.

check_boxKey Events · Financing and Capital Events · RDGT

• New $184.7M ATM Program Launched

  A sales agreement with Pacific Century Securities now allows Ridgetech to sell up to $184.7 million of ordinary shares in at-the-market offerings, replacing the terminated $200 million ATM program with AC Sunshine Securities.

• Massive Potential Dilution

  At the assumed offering price of $1.23 per share, the program could issue up to 150.2 million new shares, increasing outstanding shares from 3.6 million to approximately 153.8 million — a dilution of over 40x for existing shareholders.

• Prior ATM Program Terminated After Heavy Use

  The previous $200 million ATM program was terminated on July 11, 2026, after selling 3,487,171 shares, nearly doubling the outstanding share count from 39,033 (post-reverse split) to 3.6 million.

• Stock Trades Below Assumed Offering Price

  The assumed offering price of $1.23 is based on the July 27, 2026 closing price, but the stock currently trades at $0.90, near its 52-week low, which could force sales at lower prices and increase dilution.

auto_awesomeAnalysis · RDGT · Trade & Services

The prospectus supplement for Ridgetech's new at-the-market offering with Pacific Century Securities clears the way for sales of up to $184.7 million in ordinary shares. At the assumed offering price of $1.23, roughly 150 million new shares could hit the market, ballooning the share count from 3.6 million to over 153 million — a dilution of more than 40x for existing holders. This move comes just days after the company terminated its prior $200 million ATM program, which had already sold 3.5 million shares and nearly doubled the outstanding count. Trading near its 52-week low at $0.90, the stock sits well below the assumed $1.23 offering price, raising questions about achievable pricing and the extent of dilution if shares are sold at current levels. The filing also details a 3.5% agent commission and $500,000 in estimated expenses, with proceeds earmarked for working capital and general corporate purposes. Coming on the heels of a completed ATM and a recent reverse stock split, this aggressive equity financing signals urgent capital needs and substantial overhang risk for the stock.